WeVote
Log In

Bill

Bill

HB 2292

Relating to treatment of human immunodeficiency virus.

2025 Regular Session Introduced by Ben Bowman and 12 co-sponsors

Oregon enacted HIV treatment legislation (HB 2292) effective January 1, 2026, establishing new statewide protocols for managing human immunodeficiency virus care and access.

Chapter 480, (2025 Laws): Effective date January 1, 2026.
0
WeVote Research Nonpartisan
Bill Summary · HB 2292

Legislative bill overview

HB 2292 is Oregon legislation relating to the treatment of human immunodeficiency virus (HIV) that was signed into law in July 2025 and becomes effective January 1, 2026. The bill passed through both chambers of the Oregon Legislature and received gubernatorial approval. While the specific provisions aren't detailed in the available legislative action summary, it represents a formal policy change regarding HIV treatment protocols or access in Oregon.

Why is this important

HIV treatment policy directly affects public health outcomes, healthcare access, and potentially treatment costs for Oregonians living with HIV. Changes to HIV treatment frameworks can influence everything from medication availability to insurance coverage to prevention strategies. This legislation signals Oregon's legislative priorities regarding a communicable disease that affects thousands of residents statewide.

Potential points of contention

  • Treatment access equity: Questions about whether the bill ensures equitable access across rural and urban areas, and for populations with limited insurance coverage
  • Cost implications: Potential impact on healthcare system expenses and whether costs are distributed fairly across insurers, patients, and state budgets
  • Scope of treatment definition: Uncertainty about whether provisions cover prevention (like PrEP), acute treatment, long-term care, or some combination thereof

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.